Overview

Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2013-07-26
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this trial is to investigate the safety profile of liraglutide under normal conditions of use.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide